Skip to content

Opening book details…

Can I read Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19) on EtoBox?

Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19) by Amr El-Demerdash; Ahmed M. Metwaly; Afnan Hassan; Tarek Mohamed Abd El-Aziz; Eslam B. Elkaeed; Ibrahim H. Eissa; Reem K. Arafa; James D. Stockand is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19) about?

The huge global expansion of the COVID-19 pandemic caused by the novel SARS-corona virus-2 is an extraordinary public health emergency. The unavailability of specific treatment against SARS-CoV-2 infection necessitates the focus of all scientists in this direction. The reported antiviral activities of guanidine alkaloids encouraged us to run a comprehensive in silico binding affinity of fifteen guanidine alkaloids against five different proteins of SARS-CoV-2, which we investigated. The investigated proteins are COVID-19 main protease (M^pro^) (PDB ID: 6lu7), spike glycoprotein (PDB ID: 6VYB), nucleocapsid phosphoprotein (PDB ID: 6VYO), membrane glycoprotein (PDB ID: 6M17), and a non-structural protein (nsp10) (PDB ID: 6W4H). The binding energies for all tested compounds indicated promising binding affinities. A noticeable superiority for the pentacyclic alkaloids particularly, crambescidin 786 (**5**) and crambescidin 826 (**13**) has been observed. Compound **5** exhibited very good binding affinities against Mpro (ΔG = −8.05 kcal/mol), nucleocapsid phosphoprotein (ΔG = −6.49 kcal/mol), and nsp10 (ΔG = −9.06 kcal/mol). Compound **13** showed promising binding affinities against M

Who reads Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19)?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Amr El-Demerdash; Ahmed M. Metwaly; Afnan Hassan; Tarek Mohamed Abd El-Aziz; Eslam B. Elkaeed; Ibrahim H. Eissa; Reem K. Arafa; James D. Stockand
Publisher
MDPI AG
Published
2021
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Amr El-Demerdash; Ahmed M. Metwaly; Afnan Hassan; Tarek Mohamed Abd El-Aziz; Eslam B. Elkaeed; Ibrahim H. Eissa; Reem K. Arafa; James D. Stockand

Browse all works by Amr El-Demerdash; Ahmed M. Metwaly; Afnan Hassan; Tarek Mohamed Abd El-Aziz; Eslam B. Elkaeed; Ibrahim H. Eissa; Reem K. Arafa; James D. Stockand